Clicky

Novo Nordisk A/S(NVO) News

Date Title
Jul 28 Tempus AI or NVIDIA: Which is the Smarter Bet in AI-Backed Healthcare?
Jul 28 Healthcare Earnings Are Coming. 4 Big Questions for CVS, Humana, Merck, UnitedHealth, and More.
Jul 28 European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
Jul 28 15 regions chosen for groundbreaking effort to reduce cardiovascular disease
Jul 28 3 Surprisingly Underrated Stocks to Buy Right Now
Jul 28 Novo Nordisk faces 'show me' moment to boost Wegovy growth after US copycat ban
Jul 28 Kepler Capital Remains Bullish on Novo Nordisk A/S (NVO)
Jul 27 The Patients Forced to Switch From Zepbound to Wegovy
Jul 27 Leerink Partners and Jefferies Issue Bullish Ratings on Eli Lilly and Company (LLY)
Jul 27 2 Healthcare Stocks That Are Losing to the S&P 500 This Year
Jul 25 Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It
Jul 25 European regulatory authority adopts positive opinion for Novo Nordisk’s Alhemo® (concizumab), recommending label expansion to treat haemophilia A and B without inhibitors
Jul 25 Exclusive-China's Sciwind is in talks to license weight-loss drug in US, CEO says
Jul 24 European Equities Traded in the US as American Depositary Receipts Rise Slightly in Thursday Trading
Jul 24 This Weight-Loss Stock Sank After Earnings. It’s Still a Risk for Eli Lilly, Novo Nordisk.
Jul 24 Novo Nordisk (NVO) is a Top-Ranked Momentum Stock: Should You Buy?
Jul 24 West Pharma soars on profit forecast raise, lowered tariff impact estimate
Jul 24 Novo Nordisk defeated in Wegovy patent dispute by Viatris
Jul 24 Coagulation Factor Deficiency Market Research Report 2025 | Advancements in Long-Acting Clotting Factors and Gene Therapies Propel Growth - Global Forecast to 2035
Jul 23 European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading